6 employees
Bio-therapeutics company that develops and improves cell-based therapies in particular of cancer and other chronic diseases
1909
$2.3M
from 1 investors over 1 rounds
HONING BIOSCIENCES raised $2.3M on July 7, 2020
Investors: Elaia